The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc-labeled nanocolloid human serum albumin standard of care

Incidence of Axillary Recurrence in 344 Sentinel Node Negative Breast Cancer Patients after Intermediate Follow-Up

(2016) E.M. Heuts et al.   ACTA CHIRURGICA BELGICA

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial

(2010) Marieke E. Straver et al.   ANNALS OF SURGICAL ONCOLOGY

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

99mTc Nanocoll: A radiopharmaceutical for sentinel node localisation in breast cancer—In vitro and in vivo results

(2009) G.M.M. Gommans et al.   APPLIED RADIATION AND ISOTOPES

Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a “2-day” protocol

(2009) Anne M. Wallace et al.   NUCLEAR MEDICINE AND BIOLOGY

Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study

(2008) C.S.E. Bulte et al.   EJSO